IBB holdings

All 248 positions of iShares Biotechnology ETF.

Download CSV

Positions

248

Top 10 weight

49.9%

Effective holdings

29.7

1 / sum of squared weights

In stocks

99.9%

In bonds

0.0%

Outside the US

9.6%

Asset mix

Equity99.9%
Cash0.1%

Sectors

100% of stocks classified

Health Care95.1%
Technology4.7%
Materials0.0%

Countries

United States90.3%
Belgium3.4%
China2.6%
Denmark1.5%
Germany0.6%
France0.5%
United Kingdom0.3%
Canada0.2%
Spain0.1%
Ireland0.1%
Australia0.1%

Holdings

#	Holding	Type	Weight	Value	Shares / par	Country
1	GILDGilead Sciences Inc	Equity	8.37%	$881M	5,987,067	US
2	AMGNAmgen Inc	Equity	7.89%	$830M	2,036,876	US
3	VRTXVertex Pharmaceuticals Inc	Equity	7.69%	$809M	1,608,346	US
4	REGNRegeneron Pharmaceuticals Inc	Equity	5.40%	$568M	768,029	US
5	MRNAModerna, Inc. Common Stock	Equity	5.30%	$558M	2,831,111	US
6	NTRANatera, Inc. Common Stock	Equity	3.88%	$408M	1,043,364	US
7	ARGXargenx SE American Depositary Shares	Equity	3.35%	$353M	430,722	BE
8	ILMNIllumina Inc	Equity	2.94%	$309M	1,167,130	US
9	RVMDRevolution Medicines, Inc. Common Stock	Equity	2.67%	$281M	1,494,047	US
10	BIIBBiogen Inc. Common Stock	Equity	2.36%	$248M	1,136,513	US
11	ALNYAlnylam Pharmaceuticals, Inc.	Equity	2.21%	$232M	1,033,691	US
12	ONCBeOne Medicines Ltd. American Depositary Shares	Equity	2.17%	$228M	652,017	CN
13	INCYIncyte Genomics Inc	Equity	1.67%	$176M	1,557,312	US
14	UTHRUnited Therapeutics Corp	Equity	1.63%	$171M	321,290	US
15	INSMInsmed, Inc.	Equity	1.59%	$168M	1,667,139	US
16	GMABGenmab A/S ADS	Equity	1.47%	$155M	4,293,600	DK
17	ROIVRoivant Sciences Ltd. Common Shares	Equity	1.32%	$139M	4,062,136	US
18	NBIXNeurocrine Biosciences Inc	Equity	1.05%	$110M	778,831	US
19	EXELExelixis Inc	Equity	1.04%	$110M	1,859,302	US
20	CRLCharles River Laboratories International, Inc.	Equity	1.04%	$109M	365,889	US
21	ASNDAscendis Pharma A/S Ordinary Share	Equity	1.01%	$106M	477,863	US
22	MEDPMedpace Holdings, Inc. Common Stock	Equity	1.00%	$105M	174,157	US
23	HALOHalozyme Therapeutics, Inc.	Equity	0.91%	$96M	870,257	US
24	BBIOBridgeBio Pharma, Inc. Common Stock	Equity	0.84%	$88M	1,357,374	US
25	TECHBio-Techne Corp.	Equity	0.83%	$88M	1,208,837	US
26	BMRNBioMarin Pharmaceuticals Inc	Equity	0.77%	$81M	1,480,840	US
27	MDGLMadrigal Pharmaceuticals, Inc. Common Stock	Equity	0.76%	$80M	166,763	US
28	TWSTTwist Bioscience Corporation Common Stock	Equity	0.71%	$75M	494,140	US
29	PCVXVaxcyte, Inc. Common Stock	Equity	0.70%	$73M	1,126,823	US
30	TXG10x Genomics, Inc. Class A Common Stock	Equity	0.66%	$69M	898,562	US
31	BNTXBioNTech SE American Depositary Share	Equity	0.65%	$68M	741,815	DE
32	RGENRepligen Corp	Equity	0.64%	$68M	413,054	US
33	PTGXProtagonist Therapeutics, Inc	Equity	0.63%	$66M	474,329	US
34	KRYSKrystal Biotech, Inc. Common Stock	Equity	0.62%	$66M	200,765	US
35	CYTKCytokinetics Inc.	Equity	0.61%	$64M	1,034,340	US
36	KYMRKymera Therapeutics, Inc. Common Stock	Equity	0.60%	$63M	578,648	US
37	ARWRArrowhead Research Corporation	Equity	0.59%	$63M	1,030,385	US
38	AXSMAxsome Therapeutics, Inc	Equity	0.55%	$58M	341,316	US
39	TEMTempus AI, Inc. Class A Common Stock	Equity	0.55%	$58M	834,370	US
40	IONSIonis Pharmaceuticals, Inc. Common Stock	Equity	0.52%	$55M	1,262,799	US
41	PRAXPraxis Precision Medicines, Inc. Common Stock	Equity	0.51%	$54M	203,494	US
42	ALKSAlkermes Inc. plc	Equity	0.48%	$51M	1,261,466	US
43	ABVXAbivax SA American Depositary Shares	Equity	0.48%	$50M	563,192	FR
44	BRKRBruker Corporation	Equity	0.47%	$50M	860,264	US
45	SYRESpyre Therapeutics, Inc. Common Stock	Equity	0.47%	$49M	612,440	US
46	RYTMRhythm Pharmaceuticals, Inc. Common Stock	Equity	0.44%	$46M	512,370	US
47	GRALGRAIL, Inc. Common Stock	Equity	0.41%	$43M	326,702	US
48	KODKodiak Sciences Inc Common Stock	Equity	0.40%	$42M	450,624	US
49	IOVAIovance Biotherapeutics, Inc. Common Stock	Equity	0.39%	$41M	3,048,700	US
50	PTCTPTC Therapeutics, Inc.	Equity	0.37%	$39M	617,879	US
51	TVTXTravere Therapeutics, Inc. Common Stock	Equity	0.35%	$37M	708,049	US
52	COGTCogent Biosciences, Inc. Common Stock	Equity	0.34%	$36M	1,205,889	US
53	ORKAOruka Therapeutics, Inc. Common Stock	Equity	0.33%	$35M	455,838	US
54	CRSPCRISPR Therapeutics AG	Equity	0.33%	$35M	695,766	US
55	DFTXDefinium Therapeutics, Inc. Common Shares	Equity	0.32%	$34M	993,631	US
56	MIRMMirum Pharmaceuticals, Inc. Common Stock	Equity	0.32%	$33M	411,568	US
57	SRRKScholar Rock Holding Corporation Common Stock	Equity	0.31%	$32M	769,611	US
58	ADPTAdaptive Biotechnologies Corporation Common Stock	Equity	0.30%	$31M	1,200,267	US
59	IBRXImmunityBio, Inc. Common Stock	Equity	0.29%	$30M	3,047,471	US
60	ERASErasca, Inc. Common Stock	Equity	0.28%	$30M	1,909,760	US
61	CGONCG Oncology, Inc. Common stock	Equity	0.27%	$29M	454,288	US
62	CAICaris Life Sciences, Inc. Common Stock	Equity	0.26%	$27M	984,361	US
63	VCYTVeracyte, Inc.	Equity	0.25%	$27M	610,713	US
64	ACADAcadia Pharmaceuticals Inc.	Equity	0.25%	$26M	1,317,808	US
65	XENEXenon Pharmaceuticals Inc	Equity	0.24%	$26M	711,399	US
66	IDYAIDEAYA Biosciences, Inc. Common Stock	Equity	0.24%	$25M	702,894	US
67	EWTXEdgewise Therapeutics, Inc. Common Stock	Equity	0.24%	$25M	633,044	US
68	TNGXTango Therapeutics, Inc.	Equity	0.23%	$24M	1,079,998	US
69	LEGNLegend Biotech Corporation American Depositary Shares	Equity	0.23%	$24M	1,270,559	CN
70	ABCLAbCellera Biologics Inc. Common Shares	Equity	0.22%	$23M	1,932,524	CA
71	RLAYRelay Therapeutics, Inc. Common Stock	Equity	0.22%	$23M	1,327,479	US
72	TARSTarsus Pharmaceuticals, Inc. Common Stock	Equity	0.22%	$23M	319,777	US
73	CDNACareDx, Inc.	Equity	0.22%	$23M	366,683	US
74	AMLXAmylyx Pharmaceuticals, Inc. Common Stock	Equity	0.21%	$22M	823,241	US
75	DNLIDenali Therapeutics Inc. Common Stock	Equity	0.21%	$22M	1,159,651	US
76	ARQTArcutis Biotherapeutics, Inc. Common Stock	Equity	0.20%	$21M	847,969	US
77	SMMTSummit Therapeutics Inc. Common Stock	Equity	0.19%	$20M	1,181,275	US
78	IMVTImmunovant, Inc. Common Stock	Equity	0.19%	$20M	654,755	US
79	DYNDyne Therapeutics, Inc. Common Stock	Equity	0.18%	$19M	1,188,435	US
80	ELVNEnliven Therapeutics, Inc. Common Stock	Equity	0.18%	$19M	470,060	US
81	ZLABZai Lab Limited American Depositary Shares	Equity	0.17%	$18M	735,587	CN
82	BEAMBeam Therapeutics Inc. Common Stock	Equity	0.17%	$18M	727,946	US
83	ADMAADMA Biologics, Inc.	Equity	0.16%	$17M	1,663,420	US
84	NRIXNurix Therapeutics, Inc. Common stock	Equity	0.16%	$17M	766,077	US
85	VCELVericel Corporation	Equity	0.15%	$16M	392,129	US
86	RCUSArcus Biosciences, Inc.	Equity	0.15%	$16M	658,548	US
87	FTREFortrea Holdings Inc. Common Stock	Equity	0.14%	$15M	729,612	US
88	AUPHAurinia Pharmaceuticals Inc	Equity	0.14%	$15M	911,600	US
89	RXRXRecursion Pharmaceuticals, Inc. Class A Common Stock	Equity	0.14%	$15M	3,694,372	US
90	AGIOAgios Pharmaceuticals, Inc.	Equity	0.14%	$14M	451,526	US
91	SRPTSarepta Therapeutics,, Inc. Common Stock	Equity	0.14%	$14M	782,514	US
92	BCRXBioCryst Pharmaceuticals Inc	Equity	0.13%	$14M	1,699,739	US
93	ZYMEZymeworks Inc.	Equity	0.13%	$14M	534,540	US
94	VERAVera Therapeutics, Inc. Class A Common Stock	Equity	0.13%	$13M	453,109	US
95	NVAXNovavax Inc	Equity	0.13%	$13M	1,214,641	US
96	IRONDisc Medicine, Inc. Common Stock	Equity	0.13%	$13M	219,729	US
97	GRFSGrifois, S.A.	Equity	0.13%	$13M	1,800,114	ES
98	XNCRXencor, Inc.	Equity	0.13%	$13M	542,336	US
99	NTLAIntellia Therapeutics, Inc	Equity	0.12%	$13M	1,039,715	US
100	NAMSNewAmsterdam Pharma Company N.V. Ordinary Shares	Equity	0.12%	$13M	599,092	US
101	XTSLABLK CSH FND TREASURY SL AGENCY	Cash	0.12%	$13M	12,639,436	US
102	MBXMBX Biosciences, Inc. Common Stock	Equity	0.12%	$13M	236,390	US
103	GPCRStructure Therapeutics Inc. American Depositary Shares	Equity	0.12%	$12M	478,279	US
104	URGNUroGen Pharma Ltd. Ordinary Shares	Equity	0.11%	$12M	321,647	US
105	BHVNBiohaven Ltd.	Equity	0.11%	$12M	995,917	US
106	VIRVir Biotechnology, Inc. Common Stock	Equity	0.11%	$12M	1,038,242	US
107	NVCRNovoCure Limited Ordinary Shares	Equity	0.11%	$12M	811,247	US
108	QUREuniQure N.V.	Equity	0.11%	$11M	499,567	US
109	SNDXSyndax Pharmaceuticals, Inc.	Equity	0.10%	$11M	632,695	US
110	RAREUltragenyx Pharmaceutical Inc.	Equity	0.10%	$11M	696,857	US
111	MLYSMineralys Therapeutics, Inc. Common Stock	Equity	0.10%	$11M	469,951	US
112	ABSIAbsci Corporation Common Stock	Equity	0.10%	$10M	1,145,422	US
113	IMCRImmunocore Holdings plc American Depositary Shares	Equity	0.10%	$10M	351,215	GB
114	CMPSCOMPASS Pathways Plc American Depository Shares	Equity	0.10%	$10M	880,799	GB
115	LKFTLakefront Biotherapeutics American Depositary Shares	Equity	0.09%	$9.9M	336,854	BE
116	STOKStoke Therapeutics, Inc. Common Stock	Equity	0.09%	$9.9M	414,668	US
117	ANABAnaptysBio, Inc. Common Stock	Equity	0.09%	$9.9M	214,269	US
118	PGENPrecigen, Inc. Common Stock	Equity	0.09%	$9.7M	1,270,487	US
119	NUVBNuvation Bio Inc.	Equity	0.09%	$9.6M	1,946,952	US
120	TRVITrevi Therapeutics, Inc. Common Stock	Equity	0.09%	$9.6M	746,853	US
121	TSHATaysha Gene Therapies, Inc. Common Stock	Equity	0.09%	$9.1M	2,048,904	US
122	PSNLPersonalis, Inc. Common Stock	Equity	0.09%	$9.0M	557,847	US
123	REPLReplimune Group, Inc.	Equity	0.08%	$8.8M	677,795	US
124	SEPNSepterna, Inc. Common Stock	Equity	0.08%	$8.3M	226,147	US
125	JANXJanux Therapeutics, Inc. Common Stock	Equity	0.08%	$8.3M	448,735	US
126	TYRATyra Biosciences, Inc. Common Stock	Equity	0.08%	$8.2M	409,107	US
127	MNKDMannkind Corporation	Equity	0.08%	$8.1M	2,378,156	US
128	GHRSGH Research PLC Ordinary Shares	Equity	0.08%	$8.1M	394,472	IE
129	PHVSPharvaris N.V. Ordinary Shares	Equity	0.08%	$8.0M	256,223	NL
130	INBXInhibrx Biosciences, Inc. Common Stock	Equity	0.08%	$7.9M	85,172	US
131	CSTLCastle Biosciences, Inc. Common Stock	Equity	0.07%	$7.8M	232,780	US
132	MESOMesoblast Limited American Depositary Shares	Equity	0.07%	$7.8M	569,808	AU
133	ALVOAlvotech Ordinary Shares	Equity	0.07%	$7.6M	1,346,633	IS
134	STVNStevanato Group S.p.A.	Equity	0.07%	$7.4M	385,263	IT
135	KURAKura Oncology, Inc.	Equity	0.07%	$7.1M	673,950	US
136	ZBIOZenas BioPharma, Inc. Common Stock	Equity	0.07%	$6.9M	264,616	US
137	MAZEMaze Therapeutics, Inc. Common Stock	Equity	0.07%	$6.9M	265,532	US
138	RIGLRigel Pharmaceuticals Inc. (New)	Equity	0.07%	$6.9M	140,691	US
139	ANROAlto Neuroscience Inc.	Equity	0.06%	$6.7M	277,493	US
140	RAPPRapport Therapeutics, Inc. Common Stock	Equity	0.06%	$6.6M	222,639	US
141	ORICOric Pharmaceuticals, Inc. Common Stock	Equity	0.06%	$6.4M	528,508	US
142	MRVIMaravai LifeSciences Holdings, Inc. Class A Common Stock	Equity	0.06%	$6.2M	859,117	US
143	GERNGeron Corp	Equity	0.06%	$6.0M	4,924,426	US
144	MGTXMeiraGTx Holdings plc Ordinary Shares	Equity	0.06%	$5.9M	564,330	US
145	BCAXBicara Therapeutics Inc. Common Stock	Equity	0.06%	$5.8M	336,246	US
146	CGEMCullinan Therapeutics, Inc. Common Stock	Equity	0.05%	$5.6M	364,956	US
147	ALMSAlumis Inc. Common Stock	Equity	0.05%	$5.2M	746,652	US
148	PACBPacific Biosciences of California, Inc.	Equity	0.05%	$5.2M	2,256,882	US
149	ABUSArbutus Biopharma Corporation Common Stock	Equity	0.05%	$5.2M	1,236,500	US
150	ANNXAnnexon, Inc. Common Stock	Equity	0.05%	$5.1M	1,275,003	US
151	ZVRAZevra Therapeutics, Inc. Common Stock	Equity	0.05%	$5.1M	460,685	US
152	CRVSCorvus Pharmaceuticals, Inc.	Equity	0.05%	$5.1M	496,040	US
153	CTKBCytek Biosciences, Inc. Common Stock	Equity	0.05%	$5.0M	938,158	US
154	FDMT4D Molecular Therapeutics, Inc. Common Stock	Equity	0.05%	$4.9M	388,306	US
155	IRWDIronwood Pharmaceuticals, Inc. - Class A	Equity	0.05%	$4.8M	1,250,295	US
156	GLUEMonte Rosa Therapeutics, Inc. Common Stock	Equity	0.05%	$4.7M	459,436	US
157	SLDBSolid Biosciences Inc. Common Stock	Equity	0.04%	$4.5M	664,653	US
158	CADLCandel Therapeutics, Inc. Common Stock	Equity	0.04%	$4.5M	469,038	US
159	AVBPArriVent BioPharma, Inc. Common Stock	Equity	0.04%	$4.5M	268,505	US
160	WVEWave Life Sciences Ltd. Ordinary Shares	Equity	0.04%	$4.3M	1,253,444	US
161	OABIOmniAb, Inc. Common Stock	Equity	0.04%	$4.3M	930,643	US
162	DNAGinkgo Bioworks Holdings, Inc.	Equity	0.04%	$4.3M	375,819	US
163	OLMAOlema Pharmaceuticals, Inc. Common Stock	Equity	0.04%	$4.3M	544,552	US
164	SANASana Biotechnology, Inc. Common Stock	Equity	0.04%	$4.0M	1,429,232	US
165	SGMTSagimet Biosciences Inc. Series A Common Stock	Equity	0.04%	$4.0M	444,986	US
166	OPKOpko Health Inc.	Equity	0.04%	$3.9M	2,820,966	US
167	SVRASavara Inc.	Equity	0.04%	$3.8M	796,525	US
168	RGNXREGENXBIO Inc.	Equity	0.04%	$3.8M	472,852	US
169	ALTAltimmune, Inc. Common Stock	Equity	0.04%	$3.8M	1,456,402	US
170	CTMXCytomX Therapeutics, Inc.	Equity	0.03%	$3.6M	1,475,867	US
171	ARVNArvinas, Inc	Equity	0.03%	$3.4M	453,536	US
172	AURAAura Biosciences, Inc. Common Stock	Equity	0.03%	$3.4M	515,513	US
173	ACRSAclaris Therapeutics, Inc.	Equity	0.03%	$3.3M	872,663	US
174	NGNENeurogene, Inc. Common Stock	Equity	0.03%	$3.3M	123,547	US
175	DSGNDesign Therapeutics, Inc. Common Stock	Equity	0.03%	$3.1M	267,479	US
176	CTNMContineum Therapeutics, Inc. Class A Common Stock	Equity	0.03%	$3.1M	231,587	US
177	EDITEditas Medicine, Inc. Common Stock	Equity	0.03%	$3.0M	1,073,309	US
178	PRTAProthena Corporation plc Ordinary Shares	Equity	0.03%	$3.0M	347,622	US
179	MYGNMyriad Genetics Inc	Equity	0.03%	$2.9M	684,594	US
180	FLGTFulgent Genetics, Inc. Common Stock	Equity	0.03%	$2.8M	136,360	US
181	PHATPhathom Pharmaceuticals, Inc. Common Stock	Equity	0.03%	$2.8M	395,256	US
182	SLNSilence Therapeutics Plc American Depository Share	Equity	0.03%	$2.7M	288,047	GB
183	ARCTArcturus Therapeutics Holdings Inc. Common Stock	Equity	0.03%	$2.7M	208,671	US
184	PRMEPrime Medicine, Inc. Common Stock	Equity	0.03%	$2.6M	735,214	US
185	ALLOAllogene Therapeutics, Inc. Common Stock	Equity	0.02%	$2.6M	1,851,819	US
186	ENTAEnanta Pharmaceuticals, Inc	Equity	0.02%	$2.6M	213,673	US
187	AVIRAtea Pharmaceuticals, Inc. Common Stock	Equity	0.02%	$2.6M	501,365	US
188	EBSEmergent Biosolutions, Inc.	Equity	0.02%	$2.6M	376,958	US
189	CCCCC4 Therapeutics, Inc.	Equity	0.02%	$2.5M	870,364	US
190	AUTLAutolus Therapeutics plc American Depositary Share	Equity	0.02%	$2.4M	1,328,524	GB
191	CABACabaletta Bio, Inc. Common Stock	Equity	0.02%	$2.2M	1,137,495	US
192	SPRYARS Pharmaceuticals, Inc. Common Stock	Equity	0.02%	$2.2M	485,081	US
193	RCKTRocket Pharmaceuticals, Inc. Common Stock	Equity	0.02%	$2.2M	830,361	US
194	FULCFulcrum Therapeutics, Inc. Common Stock	Equity	0.02%	$2.1M	572,342	US
195	VNDAVanda Pharmaceuticals Inc.	Equity	0.02%	$2.0M	441,665	US
196	LABStandard BioTools Inc. Common Stock	Equity	0.02%	$1.9M	2,906,528	US
197	CATXPerspective Therapeutics, Inc.	Equity	0.02%	$1.9M	698,175	US
198	KYTXKyverna Therapeutics, Inc. Common Stock	Equity	0.02%	$1.8M	292,065	US
199	LXEOLexeo Therapeutics, Inc. Common Stock	Equity	0.02%	$1.7M	535,558	US
200	IMRXImmuneering Corporation Class A Common Stock	Equity	0.02%	$1.7M	446,102	US
201	TECXTectonic Therapeutic, Inc. Common Stock	Equity	0.02%	$1.7M	73,063	US
202	KROSKeros Therapeutics, Inc. Common Stock	Equity	0.02%	$1.6M	140,966	US
203	QSIQuantum-Si Incorporated Class A Common Stock	Equity	0.02%	$1.6M	1,314,392	US
204	BIOABioAge Labs, Inc. Common Stock	Equity	0.01%	$1.5M	245,107	US
205	LCTXLineage Cell Therapeutics, Inc.	Equity	0.01%	$1.5M	1,450,653	US
206	UPBUpstream Bio, Inc. Common Stock	Equity	0.01%	$1.3M	281,054	US
207	BBOTBridgeBio Oncology Therapeutics, Inc. Common Stock	Equity	0.01%	$1.3M	370,849	US
208	ACIUAC Immune SA	Equity	0.01%	$1.2M	474,997	CH
209	PEPGPepGen Inc. Common Stock	Equity	0.01%	$1.2M	491,750	US
210	ADCTADC Therapeutics SA	Equity	0.01%	$1.2M	734,042	US
211	BCYCBicycle Therapeutics plc American Depositary Shares	Equity	0.01%	$1.1M	289,661	GB
212	CDXSCodexis, Inc.	Equity	0.01%	$1.1M	788,850	US
213	AVXLAnavex Life Sciences	Equity	0.01%	$1.1M	693,221	US
214	PYXSPyxis Oncology, Inc. Common Stock	Equity	0.01%	$1.1M	528,888	US
215	TRDAEntrada Therapeutics, Inc. Common Stock	Equity	0.01%	$1.0M	185,017	US
216	SIONSionna Therapeutics, Inc. Common Stock	Equity	0.01%	$1.0M	205,899	US
217	LRMRLarimar Therapeutics, Inc. Common Stock	Equity	0.01%	$1.0M	372,413	US
218	QTRXQuanterix Corporation Common Stock	Equity	0.01%	$988K	307,687	US
219	SGAFTCASH COLLATERAL USD SGAFT	Cash	0.01%	$947K	947,000	US
220	VYGRVoyager Therapeutics, Inc. Common Stock	Equity	0.01%	$906K	382,257	US
221	TNYATenaya Therapeutics, Inc. Common Stock	Equity	0.01%	$890K	1,635,575	US
222	NBPNovaBridge Biosciences American Depositary Shares	Equity	0.01%	$889K	648,948	CN
223	HUMAHumacyte, Inc. Common Stock	Equity	0.01%	$852K	1,905,220	US
224	LENZLENZ Therapeutics, Inc. Common Stock	Equity	0.01%	$748K	211,799	US
225	TKNOAlpha Teknova, Inc. Common Stock	Equity	0.01%	$715K	84,698	US
226	BDTXBlack Diamond Therapeutics, Inc. Common Stock	Equity	0.01%	$689K	380,875	US
227	LYELLyell Immunopharma, Inc. Common Stock	Equity	0.00%	$522K	59,372	US
228	FHTXFoghorn Therapeutics Inc. Common Stock	Equity	0.00%	$484K	243,374	US
229	MENSJyong Biotech Ltd. Ordinary Shares	Equity	0.00%	$473K	225,204	TW
230	AARDAardvark Therapeutics, Inc. Common Stock	Equity	0.00%	$461K	97,773	US
231	GOSSGossamer Bio, Inc. Common Stock	Equity	0.00%	$430K	43,473	US
232	CRBUCaribou Biosciences, Inc. Common Stock	Equity	0.00%	$332K	689,792	US
233	AKEAKERO THERAPEUTICS CVR	Equity	0.00%	$330K	515,954	US
234	CLLSCellectis S.A. American Depositary Shares	Equity	0.00%	$306K	244,783	FR
235	NMRANeumora Therapeutics, Inc. Common Stock	Equity	0.00%	$286K	596,484	US
236	USDProShares Ultra Semiconductors	Cash	0.00%	$206K	206,436	US
237	IMMPImmutep Limited American Depositary Shares	Equity	0.00%	$154K	40,190	AU
238	ADROCHINOOK THERAPEUTICS INC	Equity	0.00%	$55K	320,962	US
239	ARCELLX INC CVR	Equity	0.00%	$24K	335,814	US
240	CARTESIAN THERAPEUTICS INC	Equity	0.00%	$2K	7,496	US
241	FUSION PHARMACEUTICALS INC CVR	Equity	0.00%	$1K	1,880	US
242	THRDThird Harmonic Bio, Inc. Common Stock	Equity	0.00%	$1	134,478	US
243	AKOUOS CVRS Prvt	Equity	0.00%	$2	157,087	US
244	CRGXCARGO Therapeutics, Inc. Common Stock	Equity	0.00%	$2	198,104	US
245	OMNIAB INC $12.50 VESTING Prvt	Equity	0.00%	$0	46,839	US
246	OMNIAB INC $15.00 VESTING Prvt	Equity	0.00%	$0	46,839	US
247	RTYZ6RUSSELL 2000 EMINI CME DEC 26	Derivative	0.00%	$0	31
248	IXCZ6E-MINI HEALTH CARE SECTOR DEC 26	Derivative	0.00%	$0	58

Find which other funds hold a stock by opening it and choosing "ETFs holding".

Position changes between reports

Action	Holding	Weight before	Weight after	Shares vs flows	Between reports
New position	Ascendis Pharma A/S	—	1.29%	—	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	ASNDAscendis Pharma A/S	0.96%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	GILDGilead Sciences, Inc.	7.75%	6.84%	+12.3%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	ARGXArgenx SE	3.07%	3.76%	+11.0%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	VRTXVertex Pharmaceuticals, Inc.	7.44%	8.08%	+12.5%	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	ACLXArcellx, Inc.	0.47%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	TERNTerns Pharmaceuticals, Inc.	0.46%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	FOLDAmicus Therapeutics, Inc.	0.41%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	APLSApellis Pharmaceuticals, Inc.	0.39%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	AMGNAmgen, Inc.	7.51%	7.83%	+16.8%	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	CNTACentessa Pharmaceuticals plc	0.25%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	SYRESpyre Therapeutics, Inc.	0.30%	0.54%	+17.9%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	APGEApogee Therapeutics, Inc.	0.37%	0.59%	+17.7%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	ORKAOruka Therapeutics, Inc.	0.18%	0.38%	+21.6%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	ABVXAbivax SA	0.50%	0.67%	+28.7%	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	DAWNDay One Biopharmaceuticals, Inc.	0.15%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	LEGNLegend Biotech Corp.	0.22%	0.33%	+10.3%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	TNGXTango Therapeutics, Inc.	0.18%	0.26%	+12.6%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	CMPSCompass Pathways plc	0.04%	0.12%	+28.8%	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	KALVKalVista Pharmaceuticals, Inc.	0.07%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	SRRKScholar Rock Holding Corp.	0.36%	0.41%	+18.6%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	TRVITrevi Therapeutics, Inc.	0.09%	0.14%	+11.5%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	GRALGRAIL, Inc.	0.17%	0.21%	+10.9%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	NTLAIntellia Therapeutics, Inc.	0.13%	0.17%	+15.8%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	GLUEMonte Rosa Therapeutics, Inc.	0.07%	0.11%	+23.4%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	ALMSAlumis, Inc.	0.14%	0.18%	+15.4%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	PSNLPersonalis, Inc.	0.03%	0.06%	+14.6%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	SMMTSummit Therapeutics, Inc.	0.19%	0.15%	+23.2%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	AVBPArriVent Biopharma, Inc.	0.06%	0.09%	+18.0%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	VIRVir Biotechnology, Inc.	0.08%	0.11%	+38.9%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	CADLCandel Therapeutics, Inc.	0.02%	0.05%	+43.4%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	BCAXBicara Therapeutics, Inc.	0.06%	0.09%	+15.3%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	MeiraGTx Holdings plc	0.05%	0.07%	+18.4%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	GRFSGrifols SA	0.10%	0.12%	+64.1%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	SGMTSagimet Biosciences, Inc.	0.01%	0.04%	+125.2%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	SLDBSolid Biosciences, Inc.	0.04%	0.06%	+27.3%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	ZBIOZenas Biopharma, Inc.	0.04%	0.06%	+31.5%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	GPCRStructure Therapeutics, Inc.	0.23%	0.24%	+11.9%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	TYRATyra Biosciences, Inc.	0.13%	0.11%	+19.0%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	CCCCC4 Therapeutics, Inc.	0.02%	0.04%	+19.8%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	OLMAOlema Pharmaceuticals, Inc.	0.08%	0.07%	+12.2%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	DNAGinkgo Bioworks Holdings, Inc.	0.02%	0.04%	+15.7%	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	KROSKeros Therapeutics, Inc.	0.03%	0.02%	−38.3%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	CABACabaletta Bio, Inc.	0.02%	0.03%	+63.9%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	MESOMesoblast Ltd.	0.09%	0.07%	+11.0%	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	LCTXLineage Cell Therapeutics, Inc.	0.03%	0.02%	−16.0%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	Pharvaris NV	0.07%	0.08%	+11.3%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	DSGNDesign Therapeutics, Inc.	0.03%	0.04%	+16.1%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	SLNSilence Therapeutics plc	0.01%	0.02%	+10.5%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	CTMXCytomX Therapeutics, Inc.	0.06%	0.05%	+23.0%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	ALTAltimmune, Inc.	0.04%	0.04%	+44.1%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	AURAAura Biosciences, Inc.	0.03%	0.04%	+39.0%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	MAZEMaze Therapeutics, Inc.	0.07%	0.08%	+26.4%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	ALLOAllogene Therapeutics, Inc.	0.03%	0.04%	+62.3%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	BNTXBioNTech SE	0.66%	0.66%	+11.3%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	UPBUpstream Bio, Inc.	0.02%	0.02%	+23.9%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	LKFTLakefront Biotherapeutics NV	0.10%	0.10%	+10.9%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	AUTLAutolus Therapeutics plc	0.02%	0.03%	+11.4%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	CGONCG oncology, Inc.	0.32%	0.32%	+10.7%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	Alvotech SA	0.03%	0.03%	+13.3%	Mar 31, 2026 → Jun 30, 2026 SEC

Share-count changes are measured after removing what creations and redemptions explain.

Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.